Furthermore, a study examining the serum levels of CXCL13 in convalescent COVID-19 at various severities showed that CXCL13 serum levels were elevated significantly in patients with severe COVID-19 compared to those in patients with mild, moderate, or asymptomatic disease. The gene discussed is CXCL13; the disease is COVID-19.